Suvoda Introduces AI-Driven RTSM System for Enhanced Clinical Trials
Suvoda has launched an AI-enhanced randomization and clinical trial supply management system, reducing RTSM startup timelines by up to 80%. The introduction of agentic AI aims to streamline trial processes amid rising protocol complexity and demand for efficiency.
Theia Market Signal Identification - AI Assisted
Suvoda's new randomization and clinical trial supply management system leverages agentic AI to improve operational efficiency. Key features include transforming protocol requirements into specifications, generating customization code, and managing protocol amendments, significantly accelerating project timelines.
The system can reduce startup durations to as little as two weeks, representing an 80% decrease in preliminary testing phases. This trend is mirrored in the industry, with firms like CMIC and Rivia also integrating AI technologies to address similar challenges. The demand for tailored automation solutions in clinical trials is increasing as sponsors seek to enhance quality without compromising speed.
Comments